Navigation Links
RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference
Date:3/17/2009

BOSTON, March 17 /PRNewswire/ -- RainDance Technologies, Inc., a privately held provider of innovative microdroplet-based solutions for human health and disease research, today announced it will be shipping its first commercial Sequence Enrichment Solution this month and reviewed the company's opportunities for growth at Cowen and Company's 29th Annual Health Care Conference.

The initial application of the company's RainStorm(TM) microdroplet-based technology platform focuses on targeted sequencing of the human genome, one of the fastest-growing segments of the rapidly expanding $1 billion DNA sequencing market. The company's Sequence Enrichment Solution and RDT 1000 system will enable the high-resolution analysis of genetic variation between individuals within populations at a level unmatched by current methodologies.

"We will make the first commercial shipment of our Sequence Enrichment Solution in March and presently have a backlog of orders," said Chris McNary, President and Chief Executive Officer, RainDance Technologies. "Over the next 3 years, we estimate the genomic sequence enrichment market at about $400 million, and we believe RainDance can capture a significant share."

During the last 6 months, RainDance has provided its solution to early access partners representing some of the world's leading genome research centers. These include the J. Craig Venter Institute, The Genome Center at the Washington University School of Medicine, and the Broad Institute. The company also collaborated with the Scripps Translational Science Institute to accelerate targeted genomic sequencing in its Wellderly Study of America's healthy elderly.

In targeted DNA sequencing applications, the Sequence Enrichment Solution provides researchers with higher resolution and statistical power while maximizing workflow efficiency and cost. "Our solution enables one next-generation sequencer to do what alternative technologies would require seven sequencers to complete in the same time," said McNary.

The company also reviewed the application of its RainStorm technology across a wide variety of growing life sciences and applied sciences markets.

"We have announced a consortium with sanofi aventis and Universite Louis Pasteur to develop the next generation of high-throughput screening and small molecule compound storage for drug discovery -- a $4 billion market," said McNary.

RainDance recently shared in a Massachusetts Life Sciences Center grant of $250,000 per year for 3 years to Dr. David Weitz, Mallinckrodt Professor of Physics and Applied Physics at Harvard's School of Engineering and Applied Sciences and Physics Department. The grant will fund research to develop a new form of fluorescence-activated cell sorter used to collect biochemical information about individual cells.

"We also have demonstrated proof of principle of our droplet-based technology in enzymatic detection of cell surface markers, sorting based on secreted proteins from cells, immunoassays, qPCR, and enzyme-directed evolution for industrial and biofuel applications," he said. "These studies highlight the potential of our RainStorm technology to become a true platform capable of sustaining growth for years to come."

About RainDance Technologies, Inc.

RainDance Technologies, Inc., is a provider of innovative microdroplet-based solutions for human health and disease research. The speed and simplicity of the company's exciting new technology platform enable researchers to design experiments in ways that were previously unaffordable or unimaginable. The company's RainStorm technology produces picoliter-volume droplets at a rate of 10 million per hour. Each droplet is the functional equivalent of an individual test tube and can contain a single molecule, reaction, or cell. This versatile technology can adapt proven assays for high-speed workflows with minimized process-induced bias or error.

RainDance was founded in 2004 by scientists from Harvard University; the Medical Research Centre in Cambridge, England and the ESPCI in Paris.

For more information, please visit www.raindancetech.com.

RainStorm(TM) is a trademark of RainDance Technologies, Inc.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Steven Becker

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78145


'/>"/>
SOURCE RainDance Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants
2. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis
3. RainDance Technologies to Present Workshop on Sequence Enrichment Using Innovative Microdroplet-Based Solutions at ASHG 2008
4. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
5. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
6. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
7. RainDance Dedicates New Headquarters, Manufacturing Facility
8. RainDance Technologies to Dedicate New Headquarters, Manufacturing Facility in Lexington
9. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
10. RainDance Technologies Appoints Olex Vice President, System Development
11. RainDance Appoints Kelly Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... ... agreement to acquire Algynomics, a research-stage pain diagnostics company. The Algynomics ... at increased risk for the development of chronic pain, which will allow targeted ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... no further than LaJollaCooks4u, San Diego’s premiere hands-on cooking experience. Offering everything from ... give mom an experience she won’t forget. , Guests that visit LaJollaCooks4u share ...
(Date:5/4/2016)... ... ... PBI-Gordon Corporation is pleased to announce Doug Obermann has been promoted to ... PBI-Gordon in February 1988, after finishing his masters in agronomy from Iowa State University. ... to national product manager, to helping develop, name and launch many of the most ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... Boston CEO 2016 on May 31st and June 1st at The Four Seasons ... leading executives in the life sciences, offering exclusive access to key decision makers ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):